Clarification to Budget Requirements for RFA-DA-10-005 "Targeted Library Synthesis and Screening at Novel Targets for Potential Drug Addiction Treatments and Research Tools (R21/R33)

Notice Number: NOT-DA-10-002

Key Dates
Release Date: November 20, 2009

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nia.nih.gov)

Purpose

This notice corrects the Budget requirements for RFA-DA-10-005  (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-005.html) “Targeted Library Synthesis and Screening at Novel Targets for Potential Drug Addiction Treatments and Research Tools (R21/R33).”   NIH requires detailed budgets with all applications submitted in response to funding opportunities that use the R21/R33 mechanism of support.

Although the budget period direct cost limits allowed under this announcement do not exceed $250,000 per period, applicants must use the “Research & Related Budget” form included in the Mandatory Documents section of the application package downloaded from Grants.gov for this funding announcement opportunity.
All other aspects of the FOA remain the same.

Inquiries

For further information contact:

Medications Discovery
Richard Kline, Ph.D.
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
National Institute on Drug Abuse
6001 Executive Blvd.
NSC, Room 4119, MSC 9551
Bethesda, MD 20892-9551
Telephone: (301) 443-8293
Fax: (301) 443-2599
Email: rkline@nida.nih.gov

CNS-Active Research Tool Discovery
Rao Rapaka, Ph.D.
Division of Basic Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Blvd.
NSC, Room 4282, MSC 9555
Bethesda, MD 20892-9555
Telephone: (301) 435-1304
Fax: (301) 594-6043
Email: rrapaka@nida.nih.gov